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Abstract—While deep learning approaches have shown re-
markable performance in many imaging tasks, most of these
methods rely on availability of large quantities of data. Medical
image data, however, is scarce and fragmented. Generative
Adversarial Networks (GANs) have recently been very effective
in handling such datasets by generating more data. If the datasets
are very small, however, GANs cannot learn the data distribution
properly, resulting in less diverse or low-quality results. One
such limited dataset is that for the concurrent gain of 19/20
chromosomes (19/20 co-gain), a mutation with positive prognostic
value in Glioblastomas (GBM). In this paper, we detect imaging
biomarkers for the mutation to streamline the extensive and
invasive prognosis pipeline. Since this mutation is relatively rare,
i.e. small dataset, we propose a novel generative framework the
Sequential Attribute GEnerator (SAGE), that generates detailed
tumor imaging features while learning from a limited dataset.
Experiments show that not only does SAGE generate high
quality tumors when compared to standard Deep Convolutional-
GAN (DC-GAN) and Wasserstein GAN with Gradient Penalty
(WGAN-GP), it also captures the imaging biomarkers accurately.
I. INTRODUCTION
With recent attempts towards Assistive AI and Computer-
Aided Diagnosis in the medical world, a common problem
encountered is the lack of curated data to train the networks on.
Generative Adversarial Networks (GANs) have been shown to
learn the data distribution and generate variety of data from
it, which can serve as additional data for training. However,
GANs also need data to train on and the need for data to create
more data poses a classic causality dilemma. In the proposed
research, we demonstrate a technique to generate tumor images
using limited dataset, by expanding the latent representation of
the tumor features. Such an approach would prove significant
in studying rare mutations such as 19/20 co-gain an indicator
of prognosis in brain tumors.
Clinical Background: Glioblastoma multiforme (GBM) is
the most common and aggressive form of malignant tumor,
comprising of 54% of all primary brain tumors [1], reporting
a 5-year survival rate of 5% [2]. A significant statistic is
that the survival rate has not improved in the last three
decades [2], which therefore, brings to attention the need for
accurate evaluation of prognosis and efficacy of chemotherapy.
Assessment of overall clinical outcomes typically requires a
combination of clinical, molecular and multi-modal imaging
data. This process is time consuming, invasive, cumbersome
and overloads the clinical workforce. Some of the many
factors that contribute to this are increasing incidence of GBM,
high resolution imaging, paucity of resources for molecular
testing, lack of follow-up, inconsistent data recording across
modalities, etc. As an answer to this problem, researchers
have started looking into optimizing the radiology pipeline
by estimating prognostic markers in imaging, in an attempt to
bypass the overhead caused by molecular data collection and
analysis. Among the many prognostic markers [3], [4], [5], the
19/20 co-gain is yet to be explored. In this paper, we show
that there are discriminatory imaging biomarkers indicating
mutation and that we can recreate them using SAGE.
Motivation for SAGE: One of the major challenges in
the medical analysis is lack of data. 19/20 co-gain is a rare
mutation, and is therefore, a limited dataset. Furthermore, it
also has a high inter-class similarity and intra-class diversity
(Fig 1), which makes the visual assessment of biomarkers very
unapparent to the naked eye. Any analysis using GANs will be
successful only if the GAN is capable of generating synthetic
images that capture the nuance and diversity of features in
the mutation. This implies the existence of a data distribution
that GANs can learn from. Additionally, since 19/20 co-gain
has never before been analyzed for visual manifestation in
MR Imaging (MRI), we begin by demonstrating that there is,
indeed, a presence of consistent imaging biomarkers that have
a positive correlation with presence or absence of 19/20 co-
gain. Following this, we will proceed to learn and recreate
these biomarkers using SAGE. The motivation behind devel-
oping SAGE as opposed to using DC-GAN or WGAN is that
SAGE is designed to increase the apparent size of the dataset.
In other words, to mitigate the issue of lack of data samples to
use in GAN, SAGE increases the size of dataset in latent space
by deconstructing features and offers a wider search space of
feature combinations (i.e., data distributions). We show that
SAGE learns useful features from the dataset to generates good
quality and diverse synthetic images.
The rest of the paper is organized as follows: Section 2
contains related work and contributions. Section 3 details
the technical approach. Section 4 contains the description of
dataset and evaluation setup. Section 5 presents the results and
Section 6 is conclusions.
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Fig. 1: Inter-class variability and inter-class similarity in 19/20
co-gain mutation. Images are all shown in FLAIR (fluid-
attenuated inversion recovery) MR modality. Top: No muta-
tion, Bottom: Mutation present
II. RELATED WORK AND CONTRIBUTIONS
A. Related Work
Deep learning has recently achieved remarkable success in
various aspects of automated workflow involving MR Image
Analysis such as diagnosis [6], grading [7], segmentation [8]
and other clinical outcomes [9]. Generative Adversarial Net-
works (GANs) have recently gained attention in the medical
field due to their efficacy in modeling and recreating data
distributions to tackle common issues with medical datasets
[10], [11], [12], the primary goal being data augmentation.
For MRI, GANs have been used for data augmentation [10],
segmentation [13], data anonymization [14], etc. Most of these
GANs generate the whole image at once. In our case, this ap-
proach does not necessarily generate the most detailed images.
Since we are analyzing unapparent visual manifestations, it is
critical that the tumor features be generated with sufficient
detail. For High- and Low-Grade Gliomas, there has been
some research in generating images for data augmentation
[15], [10]. Some of the research has attempted to use manifold
learning [16], attention-based learning [17], VAEs [18] etc. for
improving learning quality. Real-world medical data, however,
resides in a higher dimension with many complex attributes
operating together. Adding to this complexity, medical data
is often fragmented and scarce. With SAGE, we establish the
impact of separating features and latent space re-sampling to
increase the apparent sample space of the dataset to match the
complexity and dimensionality of the data. We propose that
this can result in significantly better-quality images.
B. Contributions
• A novel approach that can generate diverse synthetic
images from very limited datasets using feature recasting,
• Feature disentanglement and sequential generation for
higher-resolution images and added control over gener-
ated tumor properties,
• Quantitative analysis of efficacy of proposed method in
learning and recreating visually unapparent data distribu-
tion compared to naive GANs
III. TECHNICAL APPROACH
A. Overview of Approach
The Sequential Attribute GEnerator (SAGE) framework has
three modules: (a) Shape Generation module, (b) Texture
Generation module and (c) Merge module. Essentially, SAGE
generates tumor crops using (a) and (b) and then merges
the tumors with tumor-less brain slices in (c). The detailed
explanation of each of these modules is given in Section
III-B. From the overall dataset, we separate the slices of MR
Images that contain tumor vs the ones that dont. Tumors are
segmented manually from the slices that contain them to create
Tumor Crops (TC). Developing deep learning approaches for
brain tumor segmentation is an actively growing field. Some
of the best performing networks [19] will also have some
errors. If a tumor is wrongly segmented, the error will be
propagated through the other modules of SAGE, generating
incorrect tumors. We, therefore, opted for manual segmen-
tation to obtain TCs. The TCs are then subjected to simple
binary thresholding to obtain the shape masks. These will be
referred to as Binary Tumor Crops (BTCs) henceforth. The
slices that do not contain tumors are used in the merge block
input (Tumor-less Images in Figure 2) and are called Pseudo-
healthy Images (PHI). When a tumor grows in the brain, it
pushes through the healthy brain tissue. Since there is yet no
mathematical model that emulates this impact, we have used
PHIs. PHIs were a part of the brain that contained a tumor
and contain residual impact: thereby, the closest model we can
use for merging with the tumors realistically. The properties of
tumors and PHIs correspond to where the tumor can be located
in the brain. BTCs are a representation of shape of tumors
whereas TCs have the texture properties. So, we now separate
and re-sample from three macro-features: shape, texture and
location. Recasting and re-sampling of these features gives us
an apparent increase in sample space since we now have three
data distributions instead of one. Figure 2 outlines the overall
SAGE approach. The following sections provide details on the
SAGE workflow.
B. Description of Framework
In this section, we will detail each of the blocks of SAGE
as described in Section III-A. The shape generation module
of SAGE consists of a Latent-space Multiplexed Sampling
GAN (LMS-GAN). The texture generation module consists of
a Texture Alignment Network (TAN). The overall approach is
shown in Figure 2.
LMS-GAN: The Latent-space Multiplexed Sampling GAN
(LMS-GAN) is the shape generator module of SAGE. It is a
densely connected GAN framework that multiplexes between
latent space vectors of data and noise to generate a binary
mask of the tumor. The input of LMS-GAN are the BTCs.
LMS-GAN performs a non-linear mapping from the input
image or noise to the latent space. From the latent space,
the network randomly samples data points and gives it as an
input to the generator, periodically switching the latent vector
between noise (Znoise) and real data (Zreal). By randomly
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Fig. 2: Overall framework of the Sequential Attribute GEnerator (SAGE). BTC, TC and PHIs are the isolated features of real
data which are re-sampled in the Shape Generation, Tumor Generation and Merge (Location generation) blocks respectively.
sampling points from the latent space, it can generate as
many variations of an input vector to the generator as needed.
However, since the latent vector input to the generator is no
longer a feature vector from a coherent image, the generator
block is designed as a densely connected network and not a
convolutional network. To train the generator, the loss function
switches with the input data type. If the sampling is done from
Zreal, the network is trained on Mean Squared Error (MSE)
loss (Eq 1a) and if the samples are Znoise, loss is Binary
Cross-Entropy (BCE) loss (Eq 1b). The overall loss function
is shown in (Eq 2).
LX∼p(real) : Ex∼preal(x)||xreal − y||2 (1a)
LX∼p(noise) : Ex∼pnoise(x)
[
log
(
1−D(G(znoise) ))] (1b)
LLMS = Ix × LX∼p(noise) + (1− Ix)× LX∼p(real) (2)
where Ix is the indicator function which is 0 when X is data
and 1 when X is noise. The noise is sampled from random
normal distribution.G andD are Generator and Discriminator,
respectively. y is the generated image and xreal is the real
image. Zreal/noise are the latent space representations of real
and noisy inputs. This is depicted in Fig 3.
Texture Alignment Network (TAN): This module gen-
erates texture. TAN takes the Synthetic-BTCs (Syn-BTCs)
generated by LMS-GAN and assigns a texture. TAN randomly
samples a texture from the pool of TCs, learns its feature
MSE Loss
X = Real/Noise
Dense Layer
(Latent Space)
Generator
Discriminator
Binary Cross-entropy Loss
(Spatial Domain)
Zreal/Znoise
Y|Zreal
Y|Znoise
Fig. 3: Framework of Latent-space Multiplexed Sampling
(LMS) GAN
representation and aligns the distribution of Syn-TC with that
of the sampled TC distribution. The output of this block
is a synthetic tumor crop (Syn-TC). Some researchers have
performed feature reassignment [20], [21] in the past. In our
approach, we use features from Conv3, 4, 5 blocks of VGG19
and train on perceptual loss (Eq 3). We only include the deeper
layers because texture of an image is learnt in the deeper layers
of a CNN.
LTAN :
∑
i
ωi × ||gi(T )− gi(I)||2 + ||Fi(B)− Fi(I)||2 (3)
where: LTAN : overall loss function, ωi: weight of ith layer,
T: sampled TC, B: input Syn-BTC, I: output Syn-TC, Fi output
of ith layer and gi: Gram matrix of ith layer output.
Merge Block: When we merge the Syn-TCs with PHIs, we
must ensure maximum diversity and uniformity to generate
realistic images. For diversity, we randomly select location,
relative size of tumor (with respect to whole image) and
rotation angle for the Syn-TC. The values of these attributes
are chosen from a pre-defined allowed range of values. This
range is obtained from the mean and standard deviation of the
original dataset attributes so we can choose attribute properties
with a certain confidence. Once the tumor is merged, we apply
edge-tapering Gaussian filters for smoothness. The overall
framework of SAGE allows us to address the issues of image
quality because of data scarcity commonly experienced by
GAN approaches. In the following section, the results of using
SAGE framework to generate GBM images are detailed.
IV. EXPERIMENTAL SETUP
A. Description of Dataset
We use a dataset containing FLAIR MR images for a cohort
of 25 patients with known 19/20 co-gain status. The data is
divided into two classes: control class that has 19/20 co-gain
absent and the mutated class that has co-gain present. This
dataset was provided by our collaborators at Emory University.
The cohort is divided into 14 control and 11 mutated patients.
Each patient has an average of only 9 FLAIR images with
tumor, making it an average of 110 images per class (without
train-test split), this makes for an even smaller training set.
Thus, this is a very limited dataset to train GANs.
B. Evaluation Protocol
1. Qualitative Evaluation: For qualitative evaluation, we
present three types of results, each of which demonstrates
a specific strength of SAGE. One result evaluates how well
SAGE can learn the inherent data distribution of the data
and translate it into generating new tumors. This is shown
by comparing SAGE generated images with real images as
well as DC-GAN and WGAN-GP results. We chose four real
tumor crops with very different visual properties for each
class and picked corresponding generated images from all
three GANs that most closely resembled these tumors. This
provides evidence of how well SAGE can learn the properties
of highly diverse and limited data. For the second type of
results, we demonstrated how SAGE can generate a diverse
range of synthetic tumors compared to other GANs. This is an
evaluation of the robustness of SAGE towards mode-collapse
and loss of detail in generated images. For the third type
of results, we show how well SAGE can capture the quality
and detail of tumors. Thus, we zoom in into an example set
of images for each class and compare resolution and detail
between real, SAGE, DC-GAN and WGAN-GP.
2. Quantitative Evaluation: Inception Score and Structural
Similarity: We report Inception Score (IS) and Structural Sim-
ilarity Index (SSIM) to demonstrate the quality of generated
images. The Inception Score evaluates two properties: (a)
Image quality and (b) Image diversity. To assess image quality,
meaningful generated objects should have a conditional label
distribution with low entropy [22]. For ensuring diversity in
generated images, the marginal probability should have high
entropy [22]. Inception score is a combination of these two
constraints. It achieves this by calculating the KL Divergence
between the conditional and marginal distributions. The aver-
age KL divergence value of all generated images is the score.
The lowest value of IS is 1 and the highest value is the number
of classes. The SSIM is a comprehensive measure of similarity
between images. The value of SSIM lies between 0 and 1,
where 0 means the images aren’t similar at all. Ideally, we
want our images to follow the same distribution as real data
but also be different enough to ensure diversity. Therefore, we
can identify the range of 0.35-0.75 as the preferred range of
SSIM to evaluate our synthetic image quality.
3. Blind Test by Radiologists: We conducted tests for
assessing the quality of generated tumor crops via a blind
prediction test with radiologists. We asked radiologists to
manually distinguish between real and synthetic tumors. The
evaluation was done with 3 radiologists. They were provided
with control and mutated folders, each containing random
number of real and synthetic images. These images were
randomly chosen and resized to 100x100 for consistency.
Furthermore, the names of these images were replaced by
random numbers to hide any indicators that may point towards
the nature of the image. For a completely blind assessment,
the statistics of data split were not revealed to the radiologists.
The control group had a total of 92 images: 45 real and 47
synthetic while the mutated group had 82 images: 35 real and
47 synthetic images. The radiologists were then asked to mark
the images R/F (Real or Fake). These results are summarized
in Table II. Here, accuracy (ACC) is the proportion of correct
predictions made, False Positive Rate (FPR) is the proportion
of synthetic images that were mistaken as real, False Negative
Rate (FNR) is the proportion of real images mistaken as
synthetic and Precision (PR) is the proportion of true positives
over all positive calls. During our design of experiment for this
test, there were two key questions which we answered. These
questions and answers are given below:
Question 1: What is your hypothesis that you are trying to
show by having us classify them? Do you predict that a human
will or will not be able to tell the difference?
Answer 1: We want to have an expert evaluation of the
quality of generated tumor images. If the generated images
are of high quality, one will not be able to distinguish them
from real images. Based on this we can have a metric of the
quality of generated images. This will also help us to improve
the quality of generated images in the future.
Question 2: What is the reasoning for the tumor being so
tightly cropped? For us, it is very unusual to look at an image
that is only the segmented tumor. In this way, all the images
seem very strange to us. It is difficult to reliably tell the
difference because there is not much context.
Answer 2: The images are tightly cropped since only
the tumor is (synthetically) generated. Cropped images are
used for data augmentation for the training of deep learning
algorithms (to distinguish mutated/control groups) assuming
the detection/segmentation has been done perfectly. We aim to
evaluate how well the tumor features are learnt when isolated.
Yes, the context is very important for image interpretation and
currently we take that into account in the classification step
where we learn the discriminatory features.
4. Learning Discriminatory Features: We focus our eval-
uation on our primary goal: to evaluate whether SAGE can
consistently and precisely learn the desired feature distribution.
To evaluate this, we use the generated images to classify
real images. The rationale is: if SAGE-generated images can
detect discriminatory features in a real test set, then SAGE has
captured the desired data distribution unique to each class. We
compare these results using synthetic images generated using
DC-GAN and WGAN-GP to demonstrate the effectiveness
of SAGE in learning from limited data. We report accuracy,
sensitivity, specificity and dice score for a complete evaluation
of performance. Here accuracy is the proportion of total correct
predictions, sensitivity is the true positive rate, specificity is
the true negative rate and dice score is the harmonic mean of
precision (proportion of true positives over all positive calls)
and recall (sensitivity).
V. RESULTS AND DISCUSSION
We perform evaluations for qualitative and quantitative
analysis of generated tumor crops and the results of blind test
by radiologists. The results are summarized below:
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Fig. 4: Tumor crops and Whole Images generated by SAGE vs Real data and compared against DC-GAN and WGAN-GP.
The green (solid) box contains real samples, the red (dotted) box contains samples generated by SAGE, blue (dashes-medium)
contain samples generated by DC-GAN and yellow (dashes-large) contain WGAN-GP samples.
1. Qualitative Evaluation of Generated Images: We evaluate
the ability of SAGE to learn from the data distribution accu-
rately. To show that SAGE can learn the features compared
to other GANs, the tumor crops and whole slide images
generated by SAGE, DC-GAN [23] and WGAN-GP [24] are
shown in Figure 4. We use WGAN-GP over standard WGAN
because the gradient penalty has been shown to provide
superior results [24]. SAGE generates attributes sequentially,
giving us complete control over how and what kind of images
we generate. It can be seen from Figure 4 that we are able to
recreate specific tumor attributes. For comparison, we cherry-
picked the DC-GAN and WGAN-GP images that looked
visually similar to the corresponding real and SAGE image. It
can be seen that SAGE is able to recreate the detailed attributes
more faithfully.
Our goal, however, is not limited to recreating features
exactly. We also want to generate good quality images and
a diverse set of synthetic images that learn from the real
distribution. Figure 6 shows the diversity of images generated
using each of the GANs. It can be seen that DC-GAN
suffers from mode-collapse due to lack of data. WGAN-GP
is relatively better at handling it, however, given the limited
data available, it cannot combat mode-collapse and generate
detailed attributes at the same time. Therefore, we can see
Real SAGE DC-GAN WGAN-GP
Control
Mutated
Fig. 5: Comparing quality of similar-looking generated images. The purple dashed line divides control and mutated samples.
The green (solid) box contains real samples, the red (dotted) box contains samples generated by SAGE, blue (dashes-medium)
contain samples generated by DC-GAN and yellow (dashes-large) contain WGAN-GP samples.
that while WGAN-GP generates diverse images compared to
DC-GAN, it is unable to achieve the same quality of tumors
as SAGE. SAGE not only generates better quality images, but
also generates more diverse set of synthetic images. Addi-
tionally, Figure 5, zooms in on some examples of generated
images where DC-GAN and WGAN-GP fail to generate an
acceptable detail and quality of tumor image.
2. Quantitative Evaluation: As a quantitative measure, we
calculated the Inception Score of generated images. For two
classes, the score can be between 1 and 2. The closer the
score is to 2, the better our GAN performs. For SAGE, we
calculated Inception score for a total of 1000 images (500 each
of control and mutated). We calculated SSIM over the same
set. We used similar settings to evaluate Inception score and
SSIM for DC-GAN and WGAN-GP. The results are shown in
Table I. We note that SAGE gives an inception score value of
1.71 which shows that it is effective in learning both quality
and diversity of data. The SSIM value above 0.5 indicates
that visual properties of generated images are similar to real
images but since the SSIM is not too close to 1, we can infer
that there is a certain level of diversity associated with data.
3. Evaluation by Radiologists: We also report results from
a blind test conducted with our radiologists (Table II) to
demonstrate that SAGE can generate realistic looking good
TABLE I: Inception score (IS) and Structural Similarity
(SSIM) for generated images using SAGE, DC-GAN and
WGAN-GP. The number of generated images per class is 500
for each GAN.
Generative Model IS SSIM
SAGE (ours) 1.71 0.68
WGAN-GP 1.35 0.57
DC-GAN 1.12 0.32
TABLE II: Blind test for radiologists to distinguish between
real and synthetic tumor crops. The metrics shown are: ACC
- Accuracy, FPR - False Positive Rate, TNR - True Negative
Rate, PR - Precision. Row (non-shaded) are values for each
radiologist and row (shaded) is the mean value across all
radiologists.
Data class Radiologist ACC FPR FNR PR
1 0.59 0.42 0.38 0.55
Control 2 0.67 0.34 0.31 0.66
3 0.70 0.30 0.36 0.64
Mean 0.66 0.35 0.33 0.64
1 0.74 0.33 0.19 0.72
Mutated 2 0.82 0.19 0.18 0.87
3 0.76 0.30 0.20 0.77
Mean 0.77 0.27 0.19 0.79
quality tumors. Referring to Table II, we note a FPR of 35%
and 27% for control and mutated classes, respectively. We also
observe a FNR of 33% and 19%, respectively. This indicates
that SAGE is also able to generate realistic new tumors, i.e.,
learning how a new tumor would realistically grow. For the
tumors that the radiologists could detect as being synthetically
generated, we obtained feedback from the radiologists about
what features look artificial. There was an agreement among
radiologists that an image was computer generated because
one of two things: (a) a specific artifact which seemed to
be present on some of the images. Many of them had sharp
lines or a broken appearance, discontinuity. Those images
were suspected as computer generated. They also classified
”smudgy” appearance as computer generated or looking fake,
and (b) the brain cortex seemed discontinuous or abnormal on
some of the images, which was labeled as computer generated.
Further, they did not find anything about the tumors themselves
that was different between real and generated images.
Control
Mutated
SAGE WGAN-GP DC-GAN
Fig. 6: Diversity of images generated by SAGE vs WGAN-GP vs DC-GAN for both classes of tumors. The purple dashed
line divides control and mutated samples. The green (solid) box contains real samples, the red (dotted) box contains samples
generated by SAGE, blue (dashes-medium) contain samples generated by DC-GAN and yellow (dashes-large) contain WGAN-
GP samples.
TABLE III: Mutation detection using only synthetic data generated using SAGE, DC-GAN and WGAN-GP. Data is generated
using the training set of shaded row and tested on the corresponding real test set for all 10-folds. The results reported are mean
(standard deviation) over 10 folds. Row: cyan is baseline trained on real data. Metrics are - ACC: Accuracy, SEN: Sensitivity,
SPEC: Specificity and DIC: Dice Score for IL: Image Level and PL: Patient Level analyses.
Input Type Input source ACC (PL) ACC (IL) SEN (IL) SPEC (IL) DIC (IL)
Real Data 0.85 (0.12) 0.80 (0.09) 0.69 (0.09) 0.84 (0.06) 0.70 (0.07)
Tumor SAGE (ours) 0.85 (0.10) 0.81 (0.07) 0.72 (0.07) 0.87 (0.06) 0.72 (0.08)
Crops WGAN-GP 0.78 (0.08) 0.76 (0.09) 0.70 (0.12) 0.84 (0.06) 0.72 (0.09)
DC-GAN 0.74 (0.09) 0.71 (0.10) 0.68 (0.12) 0.82 (0.08) 0.68 (0.10)
Real Data 0.92 (0.08) 0.90 (0.06) 0.85 (0.07) 0.95 (0.05) 0.86 (0.08)
Whole SAGE (ours) 0.92 (0.09) 0.89 (0.07) 0.84 (0.08) 0.94 (0.04) 0.86 (0.08)
Images WGAN-GP 0.85 (0.06) 0.80 (0.07) 0.76 (0.09) 0.88 (0.05) 0.75 (0.08)
DC-GAN 0.80 (0.08) 0.78 (0.10) 0.74 (0.12) 0.84 (0.06) 0.77 (0.12)
4. Learning Discriminatory Features: This test is to demon-
strate that SAGE can consistently learn unapparent yet dis-
criminative visual properties of tumors between presence and
absence of mutation. Table III (cyan) reports the evidence of
existence of discriminative features between the two classes
(consistent high accuracy in mutation detection). Once we
establish that mutation can be detected using the classifier,
our objective is to evaluate how well SAGE is able to learn
from a limited sample space. If synthetic images learn features
accurately, then they should be equally effective in detecting
mutation. Thus, we replace the training set with synthetic
images generated using SAGE. We get similar performance
in mutation detection using the synthetic training set as we
get using real set. For the experiments in Table III, the
dataset was divided patient-wise via a 80-20 split for 10 folds.
We train ResNet18 for classification and report mean and
standard deviation. We describe two types of results: patient-
level (PL) classification and image-level (IL) classification. IL
results are the results by considering each slice independently.
PL results are obtained by computing the weighted mean
of all images of a patient. The rest of Table III reports
the results obtained using a similar training protocol, but
trained on various training sets. The three training sets are:
generated images using DC-GAN, WGAN-GP and SAGE,
respectively. The generated images for 10-folds are learnt
from the training sets of the corresponding 10-fold real data
and evaluated on corresponding test set. We evaluate whether
the generative model can consistently and accurately capture
the required distribution to distinguish between control and
mutated groups (via a 10-fold cross-validation). The test set
for every corresponding fold was kept constant across all
three experiments (SAGE, DC-GAN and WGAN-GP) for fair
comparison with baseline (cyan, real data). For training we
used pre-trained ResNet18 using Adam optimizer, learning
rate of 0.0001 with step learning rate scheduler and binary
cross-entropy loss. The visual discriminatory features between
classes are unapparent and yet classification using SAGE
images consistently performs at par with real data. Due to
this, we observe that SAGE is able to learn and recreate subtle
indicators of tumors that discern the status of mutation.
VI. CONCLUSIONS
Medical image generation is a challenging task due to
the restrictive nature of data, diversity in individual cases
and subsequently complex feature space. In this work, We
have shown that synthetic images generated by SAGE match
very closely with real data, thereby indicating that SAGE
is able to accurately capture data distribution from limited
dataset. Comparing with DC-GAN and WGAN-GP, we can
see that SAGE has superior performance in terms of capturing
diversity and detail, with an Inception score of 1.71. Upon
closer inspection of Figure 5, we can see that where other
GANs become blurry or lose features, SAGE generates de-
tailed tumors. Furthermore, due to the sequential generation
of features, we have complete control over the tumors we
generate. Therefore, the situations where other GANs overfit
and generate the same tumors repeatedly can be avoided in
SAGE. The classification tasks indicates that the classifier
trained on SAGE images performs just as well as real images,
indicating the discriminatory features correlating to presence
or absence of mutation are learnt accurately. The quantitative
and qualitative evaluation showed that SAGE is an effective
approach for generating synthetic data using limited datasets.
In addition to these analyses, the visual quality and realism of
the images was tested via the blind test. From the blind test it
can be concluded that SAGE generates realistic images and not
just recreate images from random re-sampling of features. We
notice that SAGE has an improvement of 7-12% as compared
to other methods in learning features and a consistently high
performance. Summarizing these results, we note that SAGE
learns the features and statistical model accurately. We can,
therefore, conclude that SAGE can potentially be applied to
tackle many disease and anomaly detection problems with
limited and/or fragmented data.
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